CD274 and cancer: In the context of personalized cancer immunotherapy, Dercle et al. utilized AI algorithms, including Random Forest models, to determine which routine baseline medical parameters could most effectively predict resistance to anti-PD-L1 immunotherapies and reduced overall survival (OS) in cancer patients.